Engineered clustered myoblast cell injection augments angiogenesis and muscle regeneration in peripheral artery disease

The low survival rate of administered cells due to ischemic and inflammatory environments limits the efficacy of the current regenerative cell therapy in peripheral artery disease (PAD). This study aimed to develop a new method to enhance the efficacy of cell therapy in PAD using cell sheet technolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyake, Keisuke, Miyagawa, Shigeru, Harada, Akima, Sawa, Yoshiki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899600/
https://www.ncbi.nlm.nih.gov/pubmed/35007760
http://dx.doi.org/10.1016/j.ymthe.2022.01.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899600/
https://www.ncbi.nlm.nih.gov/pubmed/35007760
http://dx.doi.org/10.1016/j.ymthe.2022.01.008

Ejemplares similares